Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial

The impact of chemotherapy resistant B cells in multiple myeloma (MM) needs to be evaluated by in vivo targeted therapy. Here we report the conclusions from a phase II randomized, placebo controlled trial adding fludarabine to the induction with cyclophosphamide-dexamethasone. Based on an interim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnsen, Hans E, Knudsen, Lene M., Mylin, Anne K, Gimsing, Peter, Gregersen, Henrik, Abildgaard, Niels, Andersen, Nils Frost, Plesner, Torben, Vangsted, Annette, Mourits-Andersen, Torben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222252/
http://dx.doi.org/10.4081/hr.2009.e11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222252/
http://dx.doi.org/10.4081/hr.2009.e11

Ejemplares similares